« Previous
Next »
Titles
- Rx price watch report: trends in retail prices of specialty prescription drugs widely used by Medicare beneficiaries : 2005 to 20091
- Rx watchdog report: trends in manufacturer prices of brand name prescription drugs used by Medicare beneficiaries 2002 to 20071
- Rx watchdog report: trends in manufacturer prices of generic prescription drugs used by Medicare beneficiaries 2003 to 20071
- Rx watchdog report: trends in manufacturer prices of prescription drugs used by Medicare beneficiaries, 2008 year-end update1
- Searching for savings in Medicare drug price negotiations1
- Summary of recent and proposed changes to Medicare prescription drug coverage and reimbursement1
- The Medicare drug benefit coverage gap: the basics1
- The effect of Medicare Part D on evergreening, generic entry, and drug prices1
- The risk of misuse and diversion of buprenorphine for opioid use disorder in Medicare Part D continues to appear low: 20221
- What's in the administration's 5-part plan for Medicare Part D and what would it mean for beneficiaries and program savings?1
- What’s the latest on Medicare drug price negotiations?1
